Suven Life Sciences Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 116.93 million compared to INR 135.39 million a year ago. Revenue was INR 328.23 million compared to INR 219.88 million a year ago.

Net loss was INR 1,050.76 million compared to INR 1,182.68 million a year ago. Basic loss per share from continuing operations was INR 4.82 compared to INR 6.63 a year ago. Diluted loss per share from continuing operations was INR 4.82 compared to INR 6.63 a year ago.